Screening for Hematology Branch Protocols
This study is designed to screen people who might be interested in joining other research studies at the National Heart, Lung, and Blood Institute (NHLBI). It helps determine if you are healthy enough and meet the specific requirements to safely participate in those studies, which focus on blood-related diseases and disorders. This could also involve screening healthy volunteers or potential donors for bone marrow transplant studies. The main goal is to see if you are eligible for an active NHLBI research study. If you are not eligible for a study, recommendations for other treatment options will be provided to your doctor.
- Study design
- This is an observational study aiming to enroll up to 10,000 participants. It does not involve specific interventions or treatments.
- What's involved
- Not specified in the trial record.
- Compensation
- Not stated in the trial record.
- Follow-up
- Your clinical, imaging, and laboratory assessments will be measured on an ongoing basis.
AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.
Screening for Hematology Branch Protocols
At a glance
Conditions
Where it's being run
1 sites across 1 statesStudy leadership
- David J Young, M.D. · PRINCIPAL_INVESTIGATOR · National Heart, Lung, and Blood Institute (NHLBI)
Who to contact
This trial hasn't published a contact. View it on ClinicalTrials.gov
What this trial measures
- Primary endpoint is the results of clinical, imaging and laboratory assessments.ongoing
Results of clinical, imaging and laboratory assessments